With tablets and capsules convenient for patients to take and cost-effective to manufacture, it’s little wonder that oral delivery is the preferred route of administration for most pharmaceutical development projects. Yet current discovery strategies are increasingly resulting in larger, more lipophilic drug candidates. It’s thought that up to...